Lymphoma - Hodgkin - Childhood


Reporting from ASCO 2023, Alex Herrera discusses the results from the SWOG study on nivolumab in advanced stage classic Hodgkin Lymphoma.
Abstract: LBA4 - SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL), presented by Alex Herrera.
The ESMO Educational Videos series features renowned experts in oncology sharing their knowledge on a variety of subjects. Full series here https://oncologypro.esmo.org/o....ncology-news/esmo-vi
Produced by the European Society for Medical Oncology
http://www.esmo.org


To learn more about Pediatric Otolaryngology at Children’s Hospital Colorado, visit our website: https://www.childrenscolorado.....org/doctors-and-depa
Lymph nodes are part of the immune system and help fight infection. However, sometimes they can get swollen when fighting infection or due to cancer. In these cases, lymph node removal surgery may be needed. See what to expect from neck lymph node surgery and recovery in this video.


Introduction
SIOP CEDAR project, in a collaboration with International Pediatric Association (IPA), aims to improve the knowledge and understanding of general healthcare providers about the initial care of pediatric patients suspected of having cancer, and to provide information to help earlier diagnosis and referral of cases of pediatric cancer. This webinar included live expert talks, panel discussion followed by an interactive Q&A section.
Presenters
Case Scenario - Dr. Ganda Ilmana (Indonesia)
When to suspect Hodgkin Lymphoma? - Dr. Mauricio Castellanos (Guatemala)
Approach for diagnosis, initial management, and referral - Dr. Jennifer Geel (South Africa)
Panelists
Dr. Ramandeep Arora (India)
Dr. Francesco Ceppi (Canada)
Dr. Szymon Skoczen (Poland)
Moderators
Dr. Reineke Schoot, SIOP Education and Training Committee (Netherlands)
Dr. Maya Prasad, SIOP Education and Training Committee (India)
Dr. Basim Al-Zoubi, International Pediatric Association (Jordan)
Previous and forthcoming seminars
For more information about previous and forthcoming
seminars please go to https://siop-online.org/cedar/
CEDAR Project
The SIOP Education and Training Committee is glad to announce the launch of the “Childhood Cancer Early Diagnosis and Appropriate Referral (CEDAR) project”, in collaboration with the International Pediatric Association (IPA). The main objective of the CEDAR Project is to improve the knowledge and understanding of general health care providers, including paediatricians, family practitioners, and community nurses, involved in the initial care, diagnostic workup, and referral of paediatric patients suspected of having cancer.
Practical Advice in monthly webinars
By providing practical advice from oncology experts from around the world, we aim to improve the outcomes of children with cancer in resource-limited settings where delayed diagnosis, misdiagnosis, and underdiagnosis significantly impact cancer-related morbidity and mortality. In the first phase of the CEDAR project, SIOP and IPA are organizing a series of monthly webinars (September 2022 to March 2023) to highlight the importance of early diagnosis, with a focus on the six WHO index cancers (acute lymphoblastic leukaemia, Hodgkin lymphoma, Burkitt’s lymphoma, Wilms tumour, retinoblastoma, and low-grade glioma). There will also be a discussion session with an international expert panel in each of these webinars.


At age 16, Greg Aune was diagnosed with Hodgkin’s Lymphoma and was successfully cured of his disease after undergoing one year of chemotherapy and radiation treatments. His cancer experience led Dr. Aune down a path to becoming a pediatric oncologist and physician scientist.
In this video, Dr. Aune discusses issues of long-term survivorship care and care planning as part of the NCCS Cancer Policy Matters "20 Years Later" special blog series marking the 20th anniversary of the "Imperatives for Quality Cancer Care." The sixth principle of the Imperatives states, “People with histories of cancer have the right to continued medical follow-up with basic standards of care that include the specific needs of long-term survivors.” Read more at www.cancerpolicymatters.org